Companies/CA/RKV

RAKOVINA THERAPEUTICS INC.

Last · TSXVC$0.22-0.005 (-2.22%)live · yahoo · 5h ago
Vol 1.6K ≈ 345
Market cap——
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume1.6Ksession

Issuer

Legal nameRAKOVINA THERAPEUTICS INC.
HQCanada (CA)
ListingCA RKV
ISINCA75103L3092
LEI254900O0YVEUNI9UM016
SectorHealthcare
IndustryBiotechnology & Medical Research
CurrencyCAD
Entity registrytsx:RKV
Org IDRKV
Websitewww.rakovinatherapeutics.com
LinkedIn
AddressRakovina Therapeutics, Inc. 999 West Broadway V5Z 1K5, Vancouver
Loading chart…

Upcoming earnings

1 event
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
—
Est. revenue
0
View upcoming earnings →

Press & signals

3 of 7 recent
  • GlobeNewswire

    Rakovina Therapeutics Partners with Boston-based Celvion Therapeutics to Leverage AI and Real-World Clinical Data for Precision Cancer Drug Development

  • GlobeNewswire

    Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member

  • GlobeNewswire

    Rakovina Therapeutics Announces Q2 2026 Financial Results and Provides Corporate Update

The rest of this company's wire — with summaries and source links — is part of Pro.

See plans